Abstract
Joint venture between GlaxoSmithKline and Pfizer in HIV illustrates opportunities to develop combination pills to challenge current market leaders.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany
BMC Public Health Open Access 17 March 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Hughes, B. Tapping into combination pills for HIV. Nat Rev Drug Discov 8, 439–440 (2009). https://doi.org/10.1038/nrd2917
Issue Date:
DOI: https://doi.org/10.1038/nrd2917